NAG7 activators represent a specialized category of compounds designed to target and enhance the activity of the NAG7 protein. NAG7, or N-Acetylglucosaminidase 7, is an enzyme that plays a vital role in the metabolism of complex carbohydrates, specifically in the hydrolysis of N-acetylglucosamine (GlcNAc) residues from glycoproteins and glycolipids. This enzymatic activity is crucial in the lysosomal degradation pathway, as NAG7 participates in the catabolism of glycoconjugates and the recycling of their components. Activators of NAG7 are designed to upregulate its biological activity or stability, potentially influencing its role in carbohydrate catabolism and lysosomal function. These activators may encompass a range of chemical structures, from small organic molecules to larger biomolecules, each selectively interacting with NAG7 to modulate its enzymatic function within cells.
Research into NAG7 activators typically involves a multidisciplinary approach, combining techniques from enzymology, cell biology, and biochemistry to elucidate their effects on NAG7 function and their impact on lysosomal carbohydrate metabolism. Scientists investigate the interaction between NAG7 and its activators by examining changes in its enzymatic activity, substrate specificity, and lysosomal trafficking. Commonly used techniques include enzyme assays to measure NAG7 catalytic activity, substrate profiling to assess its hydrolytic preferences, and cellular trafficking assays to monitor its localization within lysosomes. Additionally, cell and animal models of lysosomal storage disorders may be employed to study the consequences of NAG7 activation on the clearance of glycoconjugates and lysosomal function. Through these investigations, researchers aim to understand the specific carbohydrate substrates targeted by NAG7, how its activity is regulated, and how modulation by specific activators can impact lysosomal carbohydrate metabolism, contributing to a deeper understanding of lysosomal function and cellular homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can activate adenylate cyclase, raising cAMP levels and potentially influencing lncRNA expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C which may lead to changes in cellular signaling and gene expression including lncRNAs. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride affects glycogen synthase kinase-3 (GSK-3) activity and may indirectly influence gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates gene expression via retinoic acid receptors, which may impact lncRNA expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can alter methylation patterns and potentially affect lncRNA expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a primary female sex hormone, it can modulate gene expression, possibly including lncRNAs like LINC00312. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
A cAMP analog that can mimic the effect of cAMP and potentially influence lncRNA expression. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that raises cAMP levels, which could affect lncRNA expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A short-chain fatty acid that inhibits histone deacetylases, potentially affecting lncRNA expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
A compound that binds to DNA and may influence transcription, including that of lncRNAs. | ||||||